Triton X-100

Triton X-100 has wide ranging proven applications and benefits in the life sciences and biopharmaceutical production sectors. It is a non-ionic detergent that disrupts lipid interactions while leaving protein interactions intact. It is used in biopharmaceutical medicines to ensure they are safe by enabling the removal of potential viruses from medicines without affecting the quality of the active pharmaceutical ingredient. Patient Safety is the primary driver for the application of Triton X-100 and applications range from general purpose detergent to viral inactivation in medicinal products. 

On March 23^rd, 2017 the European Parliament ratified REACH regulation  - the Registration, Evaluation, Authorisation and Restriction of Chemicals to include Triton X-100.

Triton X-100 belongs to the substance group 4-(1,1,3,3-tetramethylbuyl) phenol, ethoxylated which through  their degradation, have endocrine disrupting properties, for which there is scientific evidence of probable serious effects to the environment. As such, they give rise to an equivalent level of concern to those of other substances listed in points (a) to (e) of Article 57 of Regulation (EC) No 1907/2006 and, therefore, meet the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(f) of that Regulation. ¹

Enva, together with our partner Enviolet, offer a proven UV Oxidation solution to the life science, chemical & biopharmaceutical sectors for the treatment of the Triton X-100 contaminated waste waters. The UV oxidation system utilises UV and oxidation chemistry to destruct the complex organic species in aqueous waste, and to render them biodegradable. The system has been deployed in more than 600 locations across industries such as pharmaceutical, chemical, aircraft, automotive, surface treatment, metal finishing and waste management.

Download our White Paper and Data relating to the successful treatment of Triton X-100 contaminated waste process water generated by the Biopharmaceutical industry or contact us below for further information.

Download our Triton X-100 White Paper here. 

¹Official Journal of the European Union, 14.06.2177, L 150/8